Skip to main content
. 2021 Mar 3;11:5045. doi: 10.1038/s41598-021-84465-6

Figure 2.

Figure 2

B2M expression is associated with poor survival in glioma patients. Kaplan–Meier analysis of overall survival (OS), disease specific survival (DSS), and progression-free interval (PFI) based on B2M expression were performed in LGGs (A) and pan-gliomas (B) from TCGA. Kaplan–Meier analysis of OS based on B2M expression in different prognostic factors including 1p19q, MGMT, radiotherapy, IDH, chemotherapy was performed in TCGA (C) and CGGA (D).